commercialization

Small-cap biotech and industrial firms rallied on acquisitions and patent filings. Interactive Strength surged 40% after acquiring Ergatta, while biotech companies advanced through strategic initiatives and IP development.

Quantum Computing Inc. faces scrutiny over its $1.9B valuation versus just $546K revenue, with analysts citing cash burn concerns and questions about management credibility.

Psyence BioMed secures pharmaceutical-grade psychedelic supply through put option deal with PsyLabs, ensuring reliable access while maintaining liquidity for clinical development.

Coherus Oncology raises $50.1M via stock offering to fund commercial expansion of LOQTORZI and advance oncology pipeline development programs.